Faculty:

Don Flinn, PA-C
Physician Assistant, McBride Clinic, Oklahoma City, Ok.
Vice-President, Society of Physician Assistants In Rheumatology

Salahuddin Kazi, MD
Chief, Section of Rheumatology
Dallas VA North Texas Health Care System

Rick Pope, PA-C
Physician Assistant, Arthritis Center of Connecticut, Waterbury, Ct.
President, Society of Physician Assistants In Rheumatology

---

Agenda:

“Diagnosing Early Rheumatoid Arthritis”
Don Flinn, PA-C

“Current And Emerging Treatments For Rheumatoid Arthritis”
Salahuddin Kazi, MD

“A Review Of Comorbidities With Rheumatoid Arthritis”
Rick Pope, PA-C

---

Target Audience:

This activity is designed for Physicians, nurses, physician assistants and nurse practitioners who treat rheumatoid arthritis.

---

Learning Objectives:

Upon completion of this educational activity, participants should be able to:

• Discuss the potential benefits and drawbacks of diagnostic tests for rheumatoid arthritis (RA);
• Review key clinical findings in the physical exam associated with the diagnosis of RA;
• Explain the importance of early treatment intervention for RA;
• Review the mechanism of t-cell targeted therapies for RA;
• Discuss results from currently published studies on emerging modalities for RA;
• Explain the importance of assessing patients for comorbidities of RA; and
• Discuss the safety profiles of current and emerging modalities for RA

---

Accreditation:

MD/DO:
This activity is sponsored by the North American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NACCME designates this continuing medical education activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies.

Nurses: ANCC:
NACCME is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 1.5 contact hours(s). Provider #: 110-3-E-03.

Provider approved by the California Board of Registered Nursing, Provider Number 13255 for 1.5 contact hours.

---

Faculty Disclosures:

All faculty participating in Continuing Education programs sponsored by the North American Center for Continuing Medical Education are expected to disclose to the meeting audience any real or apparent conflict(s) of interest related to the content of their presentation. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations. They are simply noted here to fully inform participants.

Mr. Flinn has disclosed that he is a member of the Speakers’ Bureau for Amgen.

Dr. Kazi has disclosed that he has received research/grant support from Abbott Laboratories. He is a member of the Speakers’ Bureau for Centocor and Genentech. Dr. Kazi is an employee/officer or member of the board for the Arthritis Foundation.

Mr. Pope has disclosed that he is a member of the Speakers’ Bureau for Procter and Gamble.

---

Commercial Supporter:

This activity is supported by an educational grant from Bristol-Myers Squibb Company.

---

Sponsor:

Sponsored by the North American Center for Continuing Medical Education (NACCME).